Key result
Losartan reduces TLR2 expression, TNF-alpha, and matured dendritic cells in cyclosporine-induced rat renal injury.
Why the study?
Does Angiotensin II blockade with losartan reduce innate immune response markers in cyclosporine A-induced renal injury in rats?
Does Angiotensin II blockade with losartan reduce innate immune response markers in cyclosporine A-induced renal injury in rats?
Angiotensin II plays a pivotal role in activating the innate immune response in cyclosporine-induced renal injury, which can be attenuated by losartan.
Losartan attenuates innate immune markers in cyclosporine rat nephrotoxicity; leaves open whether angiotensin II blockade modulates similar pathways in human transplant recipients.
BACKGROUND: Angiotensin (Ang) II plays an important role in immune regulation. We evaluate the influence of the renin-angiotensin system (RAS) in the innate immune response caused by cyclosporine A (CsA)-induced renal injury. METHODS: Two separate studies were performed in Sprague Dawley rats. First, losartan (LSRT, 10 mg/kg per day) was concurrently administered with CsA (15 mg/kg per day) for 28 days. Second, AngII (435 ng/kg/min) was infused with or without LSRT for 14 days. RESULTS: AngII blockade with LSRT decreased toll-like receptor (TLR) 2 mRNA and protein expression, expression of tumor necrosis factor (TNF)-alpha mRNA, and expression of major histocompatibility complex class II antigen, which was upregulated in CsA-induced renal injury. The increased number of matured dendritic cells (DCs) in CsA-induced renal injury was also decreased by concomitant treatment of LSRT. Direct infusion of AngII increased TNF-alpha mRNA, TLR2 mRNA, and protein and the number of DCs, compared with the control rat kidney. In contrast, concomitant treatment of LSRT decreased all parameters. CONCLUSION: AngII plays a pivotal role in activating the innate immune response in CsA-induced renal injury.
No takes yet. Share an insight, caveat, or question.
Ahn et al. (2007) studied Cyclosporine A (CsA)-induced renal injury. Losartan vs. CsA alone or AngII alone was evaluated on Expression of TLR2 mRNA and protein, TNF-alpha mRNA, MHC class II antigen, and number of matured dendritic cells. Angiotensin II blockade with losartan decreased TLR2 expression, TNF-alpha, and the number of matured dendritic cells in cyclosporine A-induced renal injury in rats.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: